CONTACT US | Follow
  • Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • Making News

    ETF Daily News: How to Profit from the Rise of Macau


    3/7/14: ETF Daily News discusses the performance of gaming market Macau and mentions BJK. “Macau’s rise to prominence has been swift.”
    View article » 



    Benzinga: Interesting Similarities Among 2013's Top-Performing ETFs


    6/18/13: Todd Shriber evaluates the year’s notable ETFs and mentions BBH. He remarks that “biotech ETFs big and small have been stellar performers this year."
    View article » 



    Zacks Equity Research: Semiconductor ETFs for 2013?


    2/07/13: Zacks Equity Research reports that the semiconductor industry is "set to rebound in 2013 with the recovery projected to pick up speed in the latter part of the year" and advises investors to consider SMH as a vehicle for accessing the space.
    View article » 



  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
     

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Index Total Return Ticker

      MVPPHTR
    • Index Provider

      Market Vectors Index Solutions
    • Total Net Assets

      $320.8M
    • Shares Outstanding

      5,438,138
    • Number of Holdings

      26
    • Commencement Date

      12/20/2011
  •  
    as of 04/24/14

  • Index Key Points

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR) 

    The Index comprises: 

    U.S. exchange-listed companies that derive most of their revenues from pharmaceuticals, including companies engaged primarily in research and development as well as production, marketing and sales of pharmaceuticals

    Companies eligible for inclusion in Index: 

    • Market cap exceeding $150 million
    • Three-month average-daily-trading volume of at least $1 million
    • At least 250,000 shares traded per month

    Index provider: 

    Market Vectors Index Solutions 

  • Index Profile

    • Ticker

      MVPPHTR
    • Ticker

      MVPPHTR
    • Inception Date

      08/12/2011
    • Rebalance Frequency

      Quarterly
  • Download All Index Constituents Index Top 10 Constituents (%) as of 03/31/14

    Total Constituents: 25
    Constituent Name
    Ticker
    Weightings (%)
    Johnson & Johnson
    JNJ US
    9.55
    Novartis Ag-Adr
    NVS US
    8.60
    Pfizer Inc
    PFE US
    7.45
    Merck & Co. Inc.
    MRK US
    5.26
    Sanofi-Adr
    SNY US
    5.24
    Abbvie Inc
    ABBV US
    5.05
    Novo-Nordisk A/S-Spons Adr
    NVO US
    5.03
    Glaxosmithkline Plc-Spon Adr
    GSK US
    5.02
    Teva Pharmaceutical-Sp Adr
    TEVA US
    4.62
    Astrazeneca Plc-Spons Adr
    AZN US
    4.50
    Top 10 Total (%) 60.32
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.
  • Index Country Weightings (%)
    as of 03/31/14

    • Country

      Weightings (%)
    • U.S.

      59.6
    • UNITED KINGDOM

      9.5
    • SWITZERLAND

      8.6
    • FRANCE

      5.2
    • DENMARK

      5.0
    • ISRAEL

      4.6
    • CANADA

      4.1
    • IRELAND

      3.3
    • Total

      99.9
  • Index Sector Weightings (%)
    as of 03/31/14

    • Sector

      Weightings (%)
    • Health Care

      100.0
    • Total

      100.0